¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"calcium gout"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
¿µ¹® calcium ÇÑ±Û Ä®½·
¼³¸í   
  ½ÅüÀÇ °ÅÀÇ ¸ðµç Á¶Á÷¿¡¼­ ¹ß°ßµÇ´Â ÀüÇØÁú·Î ¿©·¯ °¡Áö ¿ªÇÒÀ» ¸ö¿¡¼­ ´ã´çÇÑ´Ù. Áß¿äÇÑ ±â´ÉÀ» »ìÆìº¸¸é ¿ì¼± Àλê°ú °áÇÕÇÏ¿© »À³ª ÀÌ»¡À» ¸¸µå´Â ¿ªÇÒÀ» ÇÑ´Ù. ±×¸®°í ¸ðµç ±ÙÀ°ÀÇ ¼öÃà¿¡ ¾ø¾î¼­´Â ¾ÈµÉ ÀüÇØÁú·Î ÀÛ¿ëÀ» ÇÑ´Ù. Ç÷¾×ÀÀ°íÀÇ ¿©·¯ ´Ü°è¿¡µµ °ü¿©ÇÑ´Ù.
¿µ¹® gout ÇÑ±Û Åëdz
¼³¸í   
  À¯ÀüÁ¤º¸¸¦ º¸°üÇϴ ¹°ÁúÀΠDNA¿Í RNA µîÀ» ÀÌ·ç´Â ÇÙ»êÀº ¿ä»êÀÇ ÇüÅ·Π¹è¼³ÀÌ µÈ´Ù. À̰ÍÀÇ ¹è¼³¿¡´Â ¿©·¯ °¡Áö È¿¼Ò°¡ ÀÛ¿ëÇÑ´Ù. ÀÌÁß¿¡¼­ HGPRT (Hypoxanthine-Guanine Phosphoribosyl Transferase)¶ó´Â È¿¼Ò´Â À̹̠¹è¼³ÀÌ µÇ·Á°í ¿ä»êÀ¸·Î º¯È¯Çϴ °úÁ¤ÀÇ ¹°ÁúÀ» ´Ù½Ã ÇÙ»êÀ¸·Î ¹Ù²Ù´Â ÀÛ¿ëÀ» Çϴ ȿ¼ÒÀÌ´Ù. ÅëdzÀ̶õ ÀÌ HGPRT¶ó´Â È¿¼Ò È°¼ºµµ°¡ °¨¼ÒµÇ¾î ¹ß»ýµÈ´Ù. ÀÌ È¿¼ÒÀǠȰ¼ºµµ°¡ °¨¼ÒµÇ¸é ÇÙ»êÀÇ ¹è¼³´Ü°è¿¡¼­ Àç»ç¿ëÀ̶ó´Â ´Ü°è°¡ ¾ø¾îÁö¹Ç·Î °úµµÇÑ ¿ä»êÀÇ »ý¼ºÀÌ ÀÖ°Ô µÈ´Ù. Ç÷Áß¿¡ °úµµÇÑ ¿ä»êÀÌ Á¸ÀçÇϰí ÀÌ ¿ä»êÀº °áÁ¤À» ¸¸µé¾î¼­ °üÀý ÁÖÀ§ ¹× ¿¬ºÎ Á¶Á÷¿¡ Ä§ÂøµÇ¾î °Ý½ÉÇÑ ¹ßÀÛ¼º °üÀýÅëÀ» ¾ß±âÇϴ ±Þ¼º ¿°Áõ¼º °üÀý¿°À» ÀÏÀ¸Å°´Â Æ¯Â¡ÀûÀΠº´ÀÌ´Ù. ¶Ç ÀÌ ¿ä»êÀÇ °áÁ¤µéÀÌ ÄáÆÏÀ̳ª ½ÉÀå¿¡ ÃàÀûµÇ¾î¼­ ÄáÆÏ ¹× ½ÉÇ÷°ü°è¿¡ Àå¾Ö°¡ ¹ß»ýÇÒ ¼öµµ À־»°úÀû Ä¡·á¸¦ ¿äÇϴ º´ÀÌ´Ù. À¯Àü ¾ç½Ä»ó º¸Åë¿°»öü ¿ì¼ºÀ¸·Î À¯ÀüÇϴ À¯Àüº´ÀÌ´Ù. º¸Åë¿°»öü ¿ì¼º À¯ÀüÀ» ÇÏÁö¸¸ ³²ÀÚ¿Í ¿©ÀÚ¿¡¼­ Ç¥Çö·üÀÌ ´Þ¶ó¼­ ³²ÀÚ°¡ 95%ÀÌ»óÀ» Â÷ÁöÇÑ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • coronary calcium scan
    °ü»óµ¿¸ÆÄ®½·½ºÄµ
  • calcium
    Ä®½·
  • calcium chloride
    ¿°È­Ä®½·
  • calcium ethylenediaminetetraacetic acid
    Ä®½·¿¡Æ¿·»µð¾Æ¹Î»ç¾Æ¼¼Æ®»ê
  • calcium gluconate
    ±Û·çÄÜ»êÄ®½·
  • calcium oxalate stone
    ¼ö»êÄ®½·µ¹
  • calcium phosphate stone
    ÀλêÄ®½·µ¹
  • calcium pump
    Ä®½·ÆßÇÁ
  • calcium-catalyzed reaction
    Ä®½·Ã˸ŹÝÀÀ
  • calcium-channel blocker
    Ä®½·Åë·ÎÂ÷´ÜÁ¦
  • abarticular gout
    ºñ°üÀýÅëdz
  • articular gout
    °üÀýÅëdz
  • asthenia gout
    ¹«·ÂÅëdz
  • chalk gout
    ¼®È¸Åëdz
  • gout
    Åëdz
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • gout
    Åëdz
  • tophaceous gout
    °áÀýÅëdz
  • calcium ethylenediaminetetraacetic acid
    Ä®½·¿¡Æ¿·»µð¾Æ¹Î»ç¾Æ¼¼Æ®»ê
  • calcium
    Ä®½·
  • calcium gluconate
    ±Û·çÄÜ»êÄ®½·
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • calcium
    Ä®½·
  • calcium chloride
    ¿°È­Ä®½·
  • calcium oxalate stone
    ¼ö»êÄ®½·µ¹
  • calcium phosphate stone
    ÀλêÄ®½·µ¹
  • calcium-catalyzed reaction
    Ä®½·Ã˸ŹÝÀÀ
  • abarticular gout
    ºñ°üÀýÅëdz
  • articular gout
    °üÀýÅëdz
  • asthenia gout
    ¹«·ÂÅëdz
  • chalk gout
    ¼®È¸Åëdz
  • gout
    Åëdz
  • interval gout
    °£Çæ±âÅëdz
  • irregular gout
    (¢¡abarticular gout) ºñ°üÀýÅëdz
  • juvenile gout
    ¼Ò¾ÆÅëdz
  • latent gout
    ÀáÀçÅëdz
  • lead gout
    ³³Åëdz
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 14 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Gout
    Åëdz(÷Ôù¦)
  • abarticular gout
    ºñ°üÀý¼º Åëdz(ުμï½àõ ÷Ôù¦).
  • articular gout
    °üÀý¼º Åëdz.
  • articular gout
    °üÀý¼º Åëdz(μï½÷×ù¦).
  • gout
    Åëdz(÷Ôù¦).
  • gout,tophus
    ÅäǪ½º, Åëdz°áÀý
  • gout,uric acid stones
    ¿ä»ê°á¼®
  • guanine gout
    ±¸¾Æ´ÑÅëdz(¡­÷Ôù¦).
  • polyarticular gout
    ´Ù°üÀý¼º Åëdz(¡­÷Ôù¦).
  • polyarticular gout
    ´Ù°üÀý¼º Åëdz(Òýμï½àõ ÷Ôù¦)
  • regular gout
    Á¤ÇüÅëdz(ïáû¡÷Ôù¦).
  • regular gout
    Á¤ÇüÅëdz(ïáû¡÷Ôù¦)
  • renal gout
    ½Å¼º Åëdz(ãìàõ÷Ôù¦).
  • renal gout
    ½Å¼º Åëdz(¡­÷Ôù¦)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • calcium gout
    Ä®½·Åëdz(¡­÷Ôù¦).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • calcium channel blocker ; calcium channel blocking drug
    Ä®½·Åë·ÎºÀ¼â¾à ¹°<Á¦>, Ä®½·Åë·Î Â÷´Ü¾à¹°<Á¦>.
  • calcium channel blocker ; calcium channel blocking drug
    Ä®½·Åë·ÎºÀ¼â¾à¹°<Á¦>, Ä®½·Åë·ÎÂ÷´Ü¾à¹°<Á¦>.
  • abarticular gout
    ºñ°üÀý¼º Åëdz(ުμï½àõ ÷Ôù¦).
  • articular gout
    °üÀý¼º Åëdz.
  • articular gout
    °üÀý¼º Åëdz(μï½÷×ù¦).
  • asthenia gout
    ¹«·Â(¼º)Åëdz.
  • atypical gout
    ÀÌÇü<ºñÁ¤Çü>Åëdz(¡­÷Ôù¦).
  • atypical gout
    ÀÌÇü<ºñÁ¤Çü>Åëdz(¡­÷Ôù¦), ºñÀüÇüÀûÅëdz(ÞªîðúþîÜ÷Ôù¦).
  • chalk gout
    ¼®È¸Åëdz(à´üé÷Ôù¦).
  • extraarticular gout
    °üÀý¿ÜÅëdz(¡­÷Ôù¦).
  • gout
    Åëdz(÷Ôù¦).
  • gout,tophus
    ÅäǪ½º, Åëdz°áÀý
  • gout,uric acid stones
    ¿ä»ê°á¼®
  • guanine gout
    ±¸¾Æ´ÑÅëdz(¡­÷Ôù¦).
  • interval gout
    °£Çæ±âÅëdz(¡­÷Ôù¦).
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • calcium folinate
    Ä®½·Æú¸®³×ÀÌÆ®
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • gout
    Åëdz(÷×ù¦)
  • calcium
    Ä®½·
  • calcium-activated factor
    Ä®½·ºÎȰ ÀÎÀÚ(Ý·üÀì×í­)
  • calcium-activated neutral proteinase
    Ä®½·ºÎȰ(Ý·üÀ) Áß¼º(ñéàõ)ÇÁ·ÎƼ³×À̽º
  • calcium chloride transformation
    ¿°È­Ä®½· º¯Çü¼ú(ܨû¡âú)
  • calcium-dependent proteinase
    Ä®½·ÀÇÁ¸(ëîðí) ÇÁ·ÎƼ³×À̽º
  • calcium-dependent regulatory protein
    Ä®½·ÀÇÁ¸ Á¶Àý´Ü¹éÁú(ëîðíðàï½Ó±ÛÜòõ)
  • calcium phosphate gel
    Àλê(×òß«)Ä®½· Á©
  • calcium pump
    Ä®½· ÆßÇÁ
  • filtrable calcium
    °¡¿©°ú(ʦÕëΦ) Ä®½·
  • free calcium
    À¯¸®(ë´×î) Ä®½·
  • unionized calcium
    ºñ(Þª)ÀÌ¿ÂÈ­ Ä®½·
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • gout
    Åëdz
  • calcium
    Ä®½·
  • calcium, milk
    Ä®½·¿ìÀ¯
  • milk of calcium
    ¿ìÀ¯ÇüÄ®½·
  • milk of calcium bile
    ¿ìÀ¯ÇüÄ®½·´ãÁó
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
ABC absolute basophil count; absolute bone conduction; acalculous biliary colic; acid balance control; a...
PRAGMATIC pregnancy, rheumatoid arthritis, acromegaly, glucose metabolism disorders, mechanical injury, amyloi...
Ca   1) Carcinoma
  2) Cancer; ¾Ï
  3) Calcium
CPPD Calcium Pyro-Phosphate Dihydrate
ECG Electro-Cardio-Graphy(-Gram); ½ÉÀüµµ
   = EKG
  1. Conducting System Structu...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
CICR Calcium Induced Calcium Release
ACP Amorphous calcium phosphate
BCP Basic calcium phosphate
45Ca2+ Calcium
Ca Calcium
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • calcium gout
    Ä®½· Åëdz
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • abarticular gout
    ºñ°üÀý¼º Åëdz
    °üÀý°ú °ü·ÃÀÌ ¾ø´Â Åëdz.
  • chalk gout
    ¼®È¸ Åëdz
  • juvenile gout
    ¿¬¼Ò¼º Åëdz
  • polyarticular gout
    ´Ù°üÀý¼º Åëdz
  • renal gout
    ½Å¼º Åëdz
  • retrocedent gout
    ³»°ø¼º Åëdz
  • rheumatic gout
    ·ù¸¶Æ¼½º¼º Åëdz
  • calcium
    Ä®½·
    »ýü Áß¿¡¼­ °¡Àå ´Ù·®À¸·Î ÇÔÀ¯µÈ ¹«±â ¹°Áú. 99% ÀÌ»óÀÌ »À³ª Ä¡¾Æ µî °æÁ¶Á÷¿¡ Á¸ÀçÇÏ¸ç °ñ°ÝÀÇ À¯Áö ¹× Ä®½·ÀÇ ÀúÀå°í·Î¼­ ÀÛ¿ë. °ÅÀÇ ¸ðµç À¯±â Á¶Á÷ ³»¿¡ µé¾î ÀÖ´Â Áß¿ä ¿ø¼Ò. Ç÷¾× ÀÀ°íÀÇ ¿©·¯ ´Ü°è¿¡¼­ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí Àֱ⠶§¹®¿¡ ÀÀ°í ÀÎÀÚ ¥³¶ó°í ºÒ·Á ¿Ô´Ù.
  • calcium balance
    Ä®½· ÆòÇü
    ü³»ÀÇ Ä®½· ³óµµ°¡ ¾ÈÁ¤µÇ¾î ÀÖ´Â »óÅÂ.
  • calcium channel
    Ä®½· ä³Î
    Ä®½·ÀÌ Åë°úÇÏ´Â µµ°ü.
  • calcium channel blocker
    Ä®½· Åë·Î ºÀ¼â ¾à¹°, Ä®½· Åë·Î Â÷´Ü ¾à¹°, Ä®½· ä³Î Â÷´ÜÁ¦
    µ¿ÀǾî=calcium channel blocking drug. 1. Ä®½·ÀÌ Åë°úÇÏ ´Â µµ°üÀ» ¸·´Â ¾à¹°. 2. Ç× Çù½ÉÁõ Á¦Á¦, Ç×°íÇ÷¾Ð Á¦Á¦, Ç× ºÎÁ¤¸Æ Á¦Á¦·Î »ç¿ëµÇ´Â ¾à¹°·Î½á, µ¿¸ÆÀÇ ÆòȰ±Ù¿¡¼­ Ä®½·ÀÇ À¯ÀÔÀ» Â÷´ÜÇÔÀ¸·Î½á ¸»ÃÊ ¼Òµ¿¸ÆÀ» ÀÌ¿ÏÇØ¼­ ½É±ÙÀÇ »ê¼Ò ¿ä±¸·®À» ÀúÇϽÃŰ´Â ±â´ÉÀ» ÇÑ´Ù. ´ëÇ¥ÀûÀÎ ¾à¹°·Î´Â, vera
  • calcium channel blocking drug
    Ä®½· Åë·Î ºÀ¼â ¾à¹°, Ä®½· Åë·Î Â÷´Ü ¾à¹°
  • calcium deposit
    ¼®È¸ Ä§Âø
    Ä¡°ú¿¡¼­ Ä¡¾Æ Ç¥¸é¿¡ Á¡ÂøµÇ¾î ÀÖ´Â °æ¼º ¶Ç´Â ¿¬¼ºÀÇ ¹°Áú.
  • calcium gluconate
    ±Û·çÄÜ »ê Ä®½·
    ±Û·çÄÜ »êÀÇ Ä®½·¿°. ¹«Ãë ¹«¹ÌÀÇ ¹é»ö °áÁ¤¼º °ú¸³ ¶Ç´Â ºÐ¸». Ä®½· º¸±Þ¿¡ Á¤Á¦ ¶Ç´Â ¾×ÀÌ »ç¿ëµÈ´Ù. ºÒÈ­¹°À̳ª ¼ö»ê Áßµ¶¿¡ ´ëÇÑ °æ±¸ ÇØµ¶Á¦ÀÌ´Ù.
  • calcium hydroxide
    ¼ö»êÈ­ Ä®½·
    ¹é»ö ºÐ¸»·Î Á¸ÀçÇÏ´Â ¿°. ±¹¼ÒÀûÀÎ ¼ö·ÅÁ¦·Î »ç¿ëµÈ´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
calcium gout <rheumatology> Chondrocalcinosis, chronic recurrent arthritis clinically similar to gout.
(27 Sep 1997)
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
arthritis, gout Joint inflammation caused by uric acid crystal deposits in the joint space An attack is usually extremely painful.The uric acid crystals are deposited in the joint fluid (synovial fluid) and joint lining (synovial lining). Intense joint inflammation occurs as white blood cells engulf the uric acid crystals, causing pain, heat, and redness of the joint tissues. The term gout commonly is used to refer to these painful arthritis attacks but gouty arthritis is only one manifeatation of gout.
(12 Dec 1998)
masked gout latent gout
retrocedent gout An obsolete term for the occurrence of severe gastric, cardiac, or cerebral symptoms during an attack of gout, especially when the joint and other symptoms suddenly subside at the same time.
Saturnine gout, gout occurring in a person with lead poisoning.
Synonym: lead gout.
Secondary gout, gout resulting from increased serum uric acid levels as a result of an antecedent disease, such as a proliferative disease of the blood and bone marrow, lead poisoning, or prolonged chronic renal failure (on dialysis).
Tophaceous gout, gout in which deposits of uric acid and urates occur as gouty tophi.
(05 Mar 2000)
gout <rheumatology> Recurrent acute arthritis of peripheral joints caused by the accumulation of monosodium urate crytals. Often presents as pain and swelling confined to one joint. The big toe joint is commonly affected.
The arthritis occurs secondary to an inherited abnormality of purine metabolism, resulting in the deposition of uric acid crystals (sodium urate) within the joint space and articular cartilage.
Usually due to overproduction of uric acid but may be a result of under excretion. The problems partly arise because neutrophils release lysosomal enzymes as a result of damage to the phagosome membrane by ingested crystals: colchicine acts to reduce the attack by inhibiting lysosome phagosome fusion.
(18 Nov 1997)
gout arthritis <rheumatology> Recurrent acute arthritis of peripheral joints caused by the accumulation of monosodium urate crytals. Often presents as pain and swelling confined to one joint. The big toe joint is commonly affected.
The arthritis occurs secondary to an inherited abnormality of purine metabolism, resulting in the deposition of uric acid crystals (sodium urate) within the joint space and articular cartilage.
Usually due to overproduction of uric acid but may be a result of under excretion. The problems partly arise because neutrophils release lysosomal enzymes as a result of damage to the phagosome membrane by ingested crystals: colchicine acts to reduce the attack by inhibiting lysosome phagosome fusion.
(18 Nov 1997)
gout diet A diet containing a minimal quantity of purine bases (meats); liver, kidney, and sweetbread especially are excluded and replaced by dairy products, fruits, and cereals; alcoholic beverages also are excluded.
Synonym: purine-free diet.
(05 Mar 2000)
gout suppressants Agents that increase uric acid excretion by the kidney (uricosuric agents), decrease uric acid production (antihyperuricaemics), or alleviate the pain and inflammation of acute attacks of gout.
(12 Dec 1998)
gout, tophaceous A form of chronic gout. Nodular masses of uric acid crystals (tophi) are deposited in different soft tissue areas of the body. Even though tophi are most commonly found as hard nodules around the fingers, at the tips of the elbows, and around the big toe, tophi nodules can appear anywhere in the body. They have been reported in unexpected areas such as in the ears, vocal cords, or around the spinal cord!
(12 Dec 1998)
primary gout Acute episodes of crystal-induced synovitis due to abnormality of purine metabolism; lower than normal urinary excretion of urate leading to hyperuricaemia and acute episodes of joint inflammation.
Synonym: primary gout.
Interval gout, an asymptomatic phase between acute attacks of gout.
Latent gout, hyperuricaemia without symptoms of gout. Often used synonymously with interval gout.
Synonym: masked gout.
(05 Mar 2000)
idiopathic gout Acute episodes of crystal-induced synovitis due to abnormality of purine metabolism; lower than normal urinary excretion of urate leading to hyperuricaemia and acute episodes of joint inflammation.
Synonym: primary gout.
Interval gout, an asymptomatic phase between acute attacks of gout.
Latent gout, hyperuricaemia without symptoms of gout. Often used synonymously with interval gout.
Synonym: masked gout.
(05 Mar 2000)
tophaceous gout Nodular masses of uric acid crystals (tophi) are deposited in different soft tissue areas of the body. Even though tophi are most commonly found as hard nodules around the fingers, at the tips of the elbows, and around the big toe, tophi nodules can appear anywhere in the body. They have been reported in unexpected areas such as in the ears, vocal cords, or around the spinal cord! tophaceous gout is always a result of chronic gout.
(12 Dec 1998)
lead gout saturnine gout
benzoylpas calcium 4-Benzamidosalicylic acid calcium salt;an antituberculous agent.
(05 Mar 2000)
calcium <element> An element taken in through the diet that is essential for a variety of bodily functions, such as neurotransmission, muscle contraction and proper heart function. Imbalances of calcium can lead to many health problems and excess calcium in nerve cells can cause their death.
(22 May 1997)
calcium-45 <radiobiology> Most easily available of the radioactive calcium-45 isotopes; beta-emitter with a half-life of 162.7 days; used as a tracer.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • gout
    ¸À;Ãë¹Ì
  • gout
    Åëdz;(ƯÈ÷,ÇÇÀÇ)¹æ¿ï;ÀÀÇ÷
  • calcium
    Ä®½·
  • calcium
    Ä®½·(±Ý¼Ó¿ø¼Ò,±âÈ£ Ca,¹øÈ£ 20)
  • calcium arsenate
    ºñ»êÄ®½·(»ìÃæÁ¦)
  • calcium carbide
    źȭĮ½·
  • calcium carbonate
    ź»êÄ®½·
  • calcium chloride
    ¿°È­Ä®½·
  • calcium hydroxide
    ¼ö»êÈ­Ä®½·;¼Ò¼®È¸
  • calcium light
    Ä®½·±¤(limelight)
  • calcium oxide
    »êÈ­Ä®½·;»ý¼®È¸
  • calcium phosphate
    ÀλêÄ®½·
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á